Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study
PaperCitations, authors & open-access status
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 378 citations, 2018 year and bronze oa status.
378
Citations
2018
Year
bronze
OA Status